Cancer Institute A national cancer institute
designated cancer center

Janice Brown

Publication Details

  • Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective.

    Brown JM, Curr Opin Infect Dis. 2005; 18 (4): 352-8

    In contrast to the recipient of a solid organ transplantation, the immunological competence of recipients of hematopoietic cell transplantation does not correlate well with the administration of non-corticosteroid immunosuppressive agents. This apparent paradox reflects the unique and dynamic conglomeration of factors that affect immune reconstitution after hematopoietic cell transplantation. The following is the second part of a review of the recent primary literature regarding exogenous immunomodulatory influences as they pertain to infections in the setting of hematopoietic cell transplantation.

    PubMedID: 15985834

Stanford Medicine Resources:

Footer Links: